Muscle function is impaired in patients with "asymptomatic" primary hyperparathyroidism

World Journal of Surgery

Volumn 38, Issue 3, 2014, Pages 549-557

  Rolighed, Lars ^a   Amstrup, Anne Kristine ^a   Jakobsen, Niels Frederik Breum ^a   Sikjaer, Tanja ^a   Mosekilde, Leif ^a   Christiansen, Peer ^a   Rejnmark, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASYMPTOMATIC DISEASE; BODY EQUILIBRIUM; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; KNEE; MALE; MIDDLE AGED; MUSCLE STRENGTH; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIMARY HYPERPARATHYROIDISM; QUALITY OF LIFE;

ASYMPTOMATIC DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; KNEE JOINT; MALE; MIDDLE AGED; MUSCLE STRENGTH; POSTURAL BALANCE; QUALITY OF LIFE; RANGE OF MOTION, ARTICULAR;

EID: 84894672122     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2273-5     Document Type: Article

References (36)

1. Bollerslev J, Marcocci C, Sosa M et al (2011) Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol 165:851-864
2. Bilezikian JP (2012) Primary hyperparathyroidism. Endocr Pract 18:781-790
3. Pemberton JDJ, Geddie KB (1930) Hyperparathyroidism. Ann Surg 92:202-211
4. Bilezikian JP, Potts JT Jr, Fuleihan G et al (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87:5353-5361
5. Silverberg SJ, Lewiecki EM, Mosekilde L et al (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:351-365
6. Morris GS, Grubbs EG, Hearon CM et al (2010) Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg 251:832-837
7. Perrier ND, Balachandran D, Wefel JS et al (2009) Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. Surgery 146:1116-1122
8. Deutch SR, Jensen MB, Christiansen PM et al (2000) Muscular performance and fatigue in primary hyperparathyroidism. World J Surg 24:102-107. doi: 10.1007/s002689910019
9. Jansson S, Grimby G, Hagne I et al (1991) Muscle structure and function before and after surgery for primary hyperparathyroidism. Eur J Surg 157:13-16
10. Hedman I, Grimby G, Tisell LE (1984) Improvement of muscle strength after treatment for hyperparathyroidism. Acta Chir Scand 150:521-524
11. Quiros RM, Alef MJ, Wilhelm SM et al (2003) Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134:675-681 discussion 681-683
12. Weber T, Eberle J, Messelhauser U et al (2012) Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. Arch Surg 15:1-7
13. Amstrup AK, Rejnmark L, Vestergaard P et al (2011) Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls: a cross-sectional study. Clin Endocrinol (Oxf) 74:130-136
14. Amstrup AK, Rejnmark L, Mosekilde L (2011) Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls. Eur J Endocrinol 165:753-760
15. Jakobsen NF, Rolighed L, Nissen PH et al (2013) Muscle function and quality of life is not impaired in familial hypocalciuric hypercalcemia (FHH): a cross-sectional study on physiological effects of inactivating variants in the calcium sensing receptor gene (CaSR). Eur J Endocrinol 169:349-357
16. Maunsell Z, Wright DJ, Rainbow SJ (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 51:1683-1690
17. Curb JD, Ceria-Ulep CD, Rodriguez BL et al (2006) Performance-based measures of physical function for high-function populations. J Am Geriatr Soc 54:737-742
18. Ambrogini E, Cetani F, Cianferotti L et al (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92:3114-3121
19. Bollerslev J, Jansson S, Mollerup CL et al (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687-1692
20. Rao DS, Phillips ER, Divine GW et al (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415-5422
21. De Wit M, Pouwer F, Gemke RJ et al (2007) Validation of the WHO-5 Well-Being Index in adolescents with type 1 diabetes. Diabetes Care 30:2003-2006
22. Arthur ST, Cooley ID (2012) The effect of physiological stimuli on sarcopenia: impact of Notch and Wnt signaling on impaired aged skeletal muscle repair. Int J Biol Sci 8:731-760
23. Mosekilde L (2008) Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf) 69:1-19
24. Holick MF (2012) Vitamin D: extraskeletal health. Rheum Dis Clin North Am 38:141-160
25. Bolland MJ, Grey AB, Orr-Walker BJ et al (2008) Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism. N Z Med J 121:18-29
26. Khan A, Grey A, Shoback D (2009) Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:373-381
27. Bilezikian JP, Khan AA, Potts JT Jr (2009) Third international workshop on the management of asymptomatic primary hyperthyroidism: guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94:335-339
28. Cetani F, Pardi E, Borsari S et al (2011) Molecular pathogenesis of primary hyperparathyroidism. J Endocrinol Invest 34(Suppl):35-39
29. Reppe S, Stilgren L, Abrahamsen B et al (2007) Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. Am J Physiol Endocrinol Metab 292:E1465-E1473
30. Smock SL, Vogt GA, Castleberry TA et al (2001) Molecular cloning and functional characterization of the canine parathyroid hormone/parathyroid hormone related peptide receptor (PTH1). Mol Biol Rep 28:235-243
31. Ward BK, Magno AL, Walsh JP et al (2012) The role of the calcium-sensing receptor in human disease. Clin Biochem 45:943-953
32. Vestergaard P, Mollerup CL, Frokjaer VG et al (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321:598-602
33. Yoshimura N, Oka H, Muraki S et al (2011) Reference values for hand grip strength, muscle mass, walking time, and one-leg standing time as indices for locomotive syndrome and associated disability: the second survey of the ROAD study. J Orthop Sci 16:768-777
34. Harbo T, Brincks J, Andersen H (2012) Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects. Eur J Appl Physiol 112:267-275
35. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50:889-896
36. Rolighed L, Vestergaard P, Heickendorff L et al (2013) BMD improvements after operation for primary hyperparathyroidism. Langenbecks Arch Surg 398:113-120